Since its introduction in the early 2000, the hybridization of PET/CT has revolutionized
medical imaging by the juxtaposition of functional PET images with high-resolution anatomic
CT images. In the clinical setting, this colocalizing capability has been primarily exploited for
oncologic purposes in which accurate attribution of biological activity specifically to tumor is
of critical importance. In contrast, the colocalization capabilities of PET/CT have not been
used to a large extent in cardiovascular (CV) disease, with CT attenuation correction of the …